# Nasal High-Flow in COPD

> **NCT03564236** · NA · RECRUITING · sponsor: **Marieke Duiverman** · enrollment: 136 (estimated)

## Conditions studied

- COPD Exacerbation

## Interventions

- **DEVICE:** Nasal High Flow Therapy
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT03564236
- **Lead sponsor:** Marieke Duiverman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-10-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-12-30
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03564236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03564236, "Nasal High-Flow in COPD". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03564236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*